Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance immune responses. In preclinical studies, it generated strong, broad ...
Activist investor Altai Capital Management called on OraSure ⁠Technologies ⁠to explore a sale, saying the medical device ⁠maker could fetch double its current share price. The hedge fund also said it ...
Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.
Five years after COVID-19 was declared a pandemic, the U.S. government has suspended its free at-home coronavirus test distribution program. The Administration for Strategic Preparedness and Response ...